Related content

Estrogen receptor α is the major driving factor for growth in tamoxifen-resistant breast cancer and supported by HER/ERK signaling

By Thrane Susan  

Breast Cancer Research and Treatment, Vol. 139, Iss. 1, 2013-05 ,pp. : 71-80

Springer Publishing Company

Access to resources Recommend Favorite

New cell culture model for aromatase inhibitor-resistant breast cancer shows sensitivity to fulvestrant treatment and cross-resistance between letrozole and exemestane

By            

International Journal of Oncology, Vol. 46, Iss. 4, 2015-01 ,pp. : 1481-1490

Spandidos Publications

Access to resources Recommend Favorite

α-eleostearic acid inhibits growth and induces apoptosis in breast cancer cells via HER2/HER3 signaling

By              

Molecular Medicine Reports, Vol. 9, Iss. 3, 2014-01 ,pp. : 993-998

Spandidos Publications

Access to resources Recommend Favorite

AMG 900, pan-Aurora kinase inhibitor, preferentially inhibits the proliferation of breast cancer cell lines with dysfunctional p53

By Kalous Ondrej   Conklin Dylan   Desai Amrita   Dering Judy   Goldstein Jennifer   Ginther Charles   Anderson Lee   Lu Ming   Kolarova Teodora   Eckardt Mark   Langerød Anita   Børresen-Dale Anne-Lise   Slamon Dennis   Finn Richard  

Breast Cancer Research and Treatment, Vol. 141, Iss. 3, 2013-10 ,pp. : 397-408

Springer Publishing Company

Access to resources Recommend Favorite

Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK/ERK1/2 and PI3K/Akt signaling pathways

By        

International Journal of Oncology, Vol. 42, Iss. 3, 2013-01 ,pp. : 1113-1119

Spandidos Publications

Access to resources Recommend Favorite